SOURCE: Aquacell Water, Inc.

March 05, 2007 11:36 ET

Aquacell Water and Dow Water Solutions Reduce Arsenic to Non-Detectable Levels in Arizona for Over Six Months

RANCHO CUCAMONGA, CA -- (MARKET WIRE) -- March 5, 2007 -- Aquacell Water, Inc. (PINKSHEETS: AQWT) announced that three arsenic removal systems designed and installed in Arizona in partnership with Dow Water Solutions, a business unit of The Dow Chemical Company, have reduced the presence of arsenic to non-detectable levels. The systems were built for the Cold Water Canyon Water Company, located in Black Canyon City, Arizona. Operating efficiently since August 2006, the systems are purifying water from the wells, bringing them into compliance with EPA regulations.

In a press release issued by Dow, Alan Greenberg, senior marketing development manager of Dow Water Solutions, stated, "Our goal is to help customers reach compliance with EPA regulations as quickly as possible, while providing them peace of mind in knowing their water treatment system will run trouble-free. Collaboration with Aquacell and Dow technology has reduced arsenic levels at Cold Water Canyon for over six months to practically zero."

Cold Water Canyon's President, Roger Wagner, said, "In choosing an Aquacell system containing ADSORBSIA™ media, we focused on system reliability and minimizing costs associated with meeting the regulations. We are extremely satisfied with the systems' performance and our choice."

The full release can be viewed at:

About Aquacell Water, Inc.

Aquacell Water, Inc. headquartered in Rancho Cucamonga, CA, designs turnkey water filtration and purification systems for municipal, industrial, commercial, and institutional applications around the world. The Company specializes in arsenic removal systems in association with media manufactured by The Dow Chemical Company. Aquacell's services include evaluation, design, engineering, manufacturing, installation, training and service.

For more information about Aquacell, visit

Contact Information

  • Contact:
    Investor Relations:
    (888) 326-5222, Ext 27